| Dr Bill Thomas Cavalli, DDS | |
|
2522 Dana St, #207, Berkeley, CA 94704 | |
| (510) 841-4323 | |
| (510) 841-4038 |
| Full Name | Dr Bill Thomas Cavalli |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 2522 Dana St, Berkeley, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073731824 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 31446 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bill Thomas Cavalli, DDS 2522 Dana St, #207, Berkeley, CA 94704 Ph: (510) 841-4323 | Dr Bill Thomas Cavalli, DDS 2522 Dana St, #207, Berkeley, CA 94704 Ph: (510) 841-4323 |
News Archive
For patients with blockages in the carotid artery that supplies blood to the brain, carotid artery stenting (a non-surgical treatment) appears to be associated with an increased risk of both short- and long-term adverse outcomes when compared with surgical treatment (carotid endarterectomy), according to a meta-analysis of previously published studies that was posted online today and will appear in the February 2011 print issue of Archives of Neurology, one of the JAMA/Archives journals.
Forest Laboratories, Inc. and Merz Pharmaceuticals GmbH announced today that NAMENDA XR(TM) (memantine hydrochloride) was approved by the U.S. Food and Drug Administration for the treatment of moderate to severe dementia of the Alzheimer's type. NAMENDA XR is a 28 mg once-daily extended-release formulation of NAMENDA.
Researchers from Boston University School of Medicine (BUSM) have found that individuals who have a long history of alcoholism, but who have been abstinent for at least a month up to many years, showed abnormal brain activity when looking at facial expressions of others.
A collaboration led by scientists at Tokyo University of Agriculture and Technology, Japan, has discovered a novel amyloid protein that induces amyloidosis in rats.
The Cambridge, Mass.-based biotechnology firm Genzyme on Monday announced it will collaborate with the not-for-profit group Medicines for Malaria Venture and the Indian pharmaceutical company Advinus Therapeutics to develop new malaria treatments, the Boston Business Journal reports.
› Verified 7 days ago
Dr. Barry Randall Liu, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 914 The Alameda, Berkeley, CA 94707 Phone: 510-526-1424 Fax: 510-524-7608 | |
Dr. James In Young Mun, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 1860 Alcatraz Ave, Berkeley, CA 94703 Phone: 510-280-6080 | |
Eric Steven Citron, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 3031 Telegraph Ave, Suite 245, Berkeley, CA 94705 Phone: 510-849-1660 Fax: 510-849-1666 | |
Tam Dinh Tran, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 115 Berkeley Sq, Berkeley, CA 94704 Phone: 510-540-8400 | |
Lucy Tsai, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 115 Berkeley Sq, Berkeley, CA 94704 Phone: 510-540-8400 | |
Dr. Marjan Rusta, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 1313 Gilman St Ste A, Berkeley, CA 94706 Phone: 510-526-7546 Fax: 510-526-1027 | |
Ms. Susan Elaine Caliri, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 851 Dwight Way, Berkeley, CA 94710 Phone: 510-845-2864 Fax: 510-845-1920 |